Drug Shortage Report for INTEGRILIN
Report ID | 9382 |
Drug Identification Number | 02240352 |
Brand name | INTEGRILIN |
Common or Proper name | Eptifibatide Injection |
Company Name | MERCK CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | EPTIFIBATIDE |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 20MG/10ML vial |
ATC code | B01AC |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2017-07-05 |
Estimated end date | 2017-08-11 |
Actual end date | 2017-08-09 |
Shortage status | Resolved |
Updated date | 2017-08-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.